BiotechTube

Lumbar Interbody Fusion with Autograft + Lumbar Interbody Fusion with NeoFuse + Lumbar Interbody Fusion with NeoFuse

Phase 2Completed
0 watching 0 views this week⚡ Active
47
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Degenerative Disc Disease

Conditions

Degenerative Disc Disease, Degenerative Spondylolisthesis, Spinal Stenosis

Trial Timeline

Sep 1, 2009 → Jul 1, 2014

NCT ID
NCT00996073

About Lumbar Interbody Fusion with Autograft + Lumbar Interbody Fusion with NeoFuse + Lumbar Interbody Fusion with NeoFuse

Lumbar Interbody Fusion with Autograft + Lumbar Interbody Fusion with NeoFuse + Lumbar Interbody Fusion with NeoFuse is a phase 2 stage product being developed by Mesoblast for Degenerative Disc Disease. The current trial status is completed. This product is registered under clinical trial identifier NCT00996073. Target conditions include Degenerative Disc Disease, Degenerative Spondylolisthesis, Spinal Stenosis.

Hype Score Breakdown

Clinical
17
Activity
12
Company
5
Novelty
5
Community
5

Clinical Trials (1)

NCT IDPhaseStatus
NCT00996073Phase 2Completed

Competing Products

17 competing products in Degenerative Disc Disease

See all competitors
ProductCompanyStageHype Score
LatozinemabAlectorPhase 3
69
YH14618 + YH14618 + YH14618 + PlaceboYuhanPhase 1/2
41
Placebo + YH14618YuhanPhase 2
52
Human Embryonic Stem Cell-Derived Retinal Pigment Epithelial CellsAstellas PharmaPhase 1/2
41
ONO-2808 + PlaceboOno PharmaceuticalPhase 1
33
Pimavanserin + PlaceboAcadia PharmaceuticalsPhase 3
72
PimavanserinAcadia PharmaceuticalsApproved
80
PimavanserinAcadia PharmaceuticalsPhase 3
72
NeoFuseMesoblastPhase 2
47
Rexlemestrocel-L + HA mixture + SalineMesoblastPhase 3
72
Single Dose MPCs Injection + Single Dose MPCs InjectionMesoblastPhase 2
47
Rexlemestrocel-L + Rexlemestrocel-L + HA Mixture + PlaceboMesoblastPhase 3
72
NeoFuseMesoblastPhase 1/2
36
NeoFuseMesoblastPhase 1/2
36
PLF with NeoFuse + PLF with NeoFuse + PLF with NeoFuseMesoblastPhase 1/2
36
Use iliac bone graft + use bone morphogenetic protein + use bone derived allograft MSCs + Use adipose tissue derived MSCs + Use amnion/placental derived MSCsBrain BiotechPhase 2/3
57
Blood sampling, skin biopsy, excreta sampling, lumbar punctureBrain BiotechPre-clinical
15

Other Products from Mesoblast

Remestemcel-L + PlaceboPhase 3
72
Remestemcel-LPhase 3
72
Rexlemestrocel-L + HA mixture + SalinePhase 3
72
Infusion of one MPC expanded cord unit and one unexpanded cord unit + Infusion of two unexpanded cord blood units.Phase 3
72
Prochymal® + Placebo + Standard of Care for GVHDPhase 3
72